
|Articles|June 15, 2012
Analysis: Drug Costs Become Bigger Issue in Cancer Care
Advertisement
In the past, money was no object when cancer specialists considered which drugs would provide the best treatment for their patients.
But some top oncologists are rethinking that stance, given the soaring costs of new cancer medicines, reduced reimbursement by insurance plans and fresh research that has identified cases where cheaper generic drugs can work just as well - or better - than expensive brand-name medications.
Source: Reuters
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Increased Risk of Recurrence in NSCLC Found After Preoperative PTNB
2
Accountable Care: Not Just for the Healthiest Patients
3
Novel Machine Learning Model Improves MASLD Detection in Type 2 Diabetes
4
CVS Pharmacy Completes Acquisition of Select Rite Aid Locations
5